Novabay Pharmaceuticals Inc
NBY
Market Cap$3.15M
Close$
Share Statistics
| Market cap | $3.15 Million |
|---|---|
| Enterprise Value | $4.88 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-2.53 |
| Beta | 0.42 |
| Outstanding Shares | 4,885,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -0.37 |
|---|---|
| PEG | -1.4 |
| Price to Sales | 0.27 |
| Price to Book Ratio | -0.54 |
| Enterprise Value to Revenue | 0.44 |
| Enterprise Value to EBIT | -1.05 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.44 |
| Debt to Equity | -16.74 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Novabay Pharmaceuticals Inc
CEO: Justin Hall